Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

The popularity of GLP-1 drugs like Ozempic for weight loss has sparked debates over misuse, eating disorder risks, and accessibility challenges.

GLP-1 drugs, originally developed for type 2 diabetes, are increasingly used off-label for weight loss, raising concerns about their impact on physical and mental health.
Experts warn that these medications may exacerbate eating disorders, particularly among vulnerable populations, and call for enhanced screening by healthcare providers.
The rise of GLP-1 drugs has fueled social pressures, especially among college students and affluent groups, contributing to stigma and secrecy around their use.
Emerging fitness trends, such as 'GLP-1 workouts,' aim to counteract muscle loss caused by these drugs, with gyms and trainers adapting programs to meet users' needs.
Pharmaceutical companies are developing oral alternatives to injectable GLP-1 medications, which could potentially improve accessibility and affordability if approved in the future.